Sponsor Pipeline

Angitia Biopharmaceuticals Guangzhou Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07557446 A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta… Osteogenesis Imperfecta (OI) Recruiting
Get alerts when Angitia Biopharmaceuticals Guangzhou Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free